Welcome to our dedicated page for Quaker Chemical SEC filings (Ticker: KWR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Understanding how raw-material prices ripple through Quaker Chemical鈥檚 diverse lubricant and process-fluid portfolio can require paging through hundreds of dense disclosures. If you have ever searched Google for 鈥淨uaker Chemical SEC filings explained simply鈥� or 鈥渦nderstanding Quaker Chemical SEC documents with AI,鈥� you know the challenge.
Stock Titan resolves that problem. Our platform delivers real-time access to every submission鈥攆rom a Quaker Chemical quarterly earnings report 10-Q filing and Quaker Chemical annual report 10-K simplified to each Quaker Chemical 8-K material events explained. AI-powered summaries extract segment margins, commodity cost commentary, and sustainability notes in plain language. You also receive instant alerts on Quaker Chemical Form 4 insider transactions real-time so you never miss executive moves. Common investor tasks become point-and-click simple:
- Compare quarter-over-quarter revenue with 鈥淨uaker Chemical earnings report filing analysis.鈥�
- Track 鈥淨uaker Chemical insider trading Form 4 transactions鈥� before market shifts.
- Review 鈥淨uaker Chemical proxy statement executive compensation鈥� without scrolling through appendices.
Every filing enters our system within minutes of hitting EDGAR, then passes through expert models that highlight what matters鈥攔aw-material sensitivity, regional demand changes, and acquisition integration costs. Whether you need a quick look at 鈥淨uaker Chemical executive stock transactions Form 4鈥� or deeper context around a new sustainability footnote, Stock Titan equips you to act decisively. Complex chemistry, simple insights.
UMB Financial Corp. (UMBF) 鈥� Form 4 filing dated 07/31/2025. Chief Credit Officer Thomas S. Terry reported an F-code transaction on 07/29/2025, indicating the disposition of shares to cover tax withholding on equity compensation.
- Shares disposed: 716 common shares at $109.20, value 鈮� $78 k.
- Post-transaction holdings: 36,022.3105 shares held directly; 5,004.343 shares held indirectly via ESOP.
Telomir Pharmaceuticals (NASDAQ: TELO) filed an 8-K disclosing that on 18 July 2025 it sold 1,100,000 common shares through its at-the-market facility at an average price of $2.6045, a premium to the prior day鈥檚 close. The block trades were placed with institutional investors and executed by Rodman & Renshaw on the StockBlock platform. Gross proceeds totalled 鈮�$2.9 million before fees; no warrants or other equity sweeteners were issued.
The transaction immediately increases cash while modestly diluting existing shareholders via the new share issuance. Because the raise was completed at a premium and without warrant overhang, the near-term balance-sheet impact is positive, though future EPS will be spread over a larger share count.
FAQ
What is the current stock price of Quaker Chemical (KWR)?
What is the market cap of Quaker Chemical (KWR)?
What is the core business of Quaker Chemical?
Which industries does Quaker Chemical serve?
How does Quaker Chemical generate its revenue?
What differentiates Quaker Chemical from its competitors?
How does the company ensure quality and operational efficiency?
What role does technology play in Quaker Chemical's operations?
How is Quaker Chemical positioned in the global market?
What measures does Quaker Chemical take to support customer success?
